Table 1_COVID-19 in acute myeloid leukemia (AML) and myelodysplastic syndrome (MDS): a propensity matched analysis (2020-2021).xlsx

Table 1_COVID-19 in acute myeloid leukemia (AML) and myelodysplastic syndrome (MDS): a propensity matched analysis (2020-2021).xlsx

Background<p>By 2023, COVID-19 had caused 6.8 million deaths in the United States. COVID-19 presents more severely in leukemia compared to solid tumors (OR 1.6, p<0.05). However, data on Acute Myeloid Leukemia (AML) and Myelodysplastic Syndrome (MDS) are limited. We investigated the mortali...

Full description

Saved in:
Bibliographic Details
Main Author: Barath Prashanth Sivasubramanian (19862490) (author)
Other Authors: Shashvat Joshi (19862493) (author), Diviya Bharathi Ravkumar (19862496) (author), Madhumithaa Jagannathan (19862499) (author), Sonia Babu (19862502) (author), Shanthi Reddy Sripathi (19862505) (author), Avinash Javvaji (19862508) (author), Priyanshu Jain (5568752) (author), Dinesh Kumar Shanmugam (19122265) (author), Bharath Duraisamy Swami Kannan (19862511) (author), Raghavendra Tirupathi (12029354) (author), Rutul Dalal (19862514) (author)
Published: 2024
Subjects:
Oncology and Carcinogenesis not elsewhere classified
AML
myelodysplastic syndrome
COVID-19
severe sepsis
ARDS
acute respiratory failure
MDS
acute myeloid leukemia and HSCT
Tags: Add Tag
No Tags, Be the first to tag this record!

Similar Items

Similar Items